Latest Balance Sheet News

Hastings Technology Metals and Wyloo have formalised their joint venture for the Yangibana Rare Earths Project, with Wyloo taking a 60% stake and cancelling A$123 million in exchangeable notes, significantly de-risking the project and reducing Hastings’ funding burden.

HealthCo Healthcare & Wellness REIT has collected all outstanding rent from Healthscope and extended a rent deferral to support the ongoing sale process, while suspending distributions to preserve liquidity.

Activeport Group Ltd has successfully raised $6.68 million through a two-tranche placement, positioning the company to accelerate its software development and target cash flow positivity in FY26.

XPON Technologies announces a significant leadership reshuffle with founder Matt Forman stepping down as CEO due to health reasons, while Mark Simari assumes the role of Executive Chair amid strategic growth initiatives.

Resolution Minerals Ltd has successfully raised $25.1 million through a heavily supported placement, positioning itself to advance its Horse Heaven Project in Idaho and prepare for a NASDAQ listing.

Highfield Resources has requested a voluntary suspension of its shares on the ASX to complete a capital raising, with trading expected to resume by 23 September 2025.

Neurizon Therapeutics has raised $5 million through an institutional placement to advance its lead ALS drug candidate NUZ-001 into a pivotal clinical trial, pending FDA clearance. The capital injection also supports manufacturing and pre-clinical development efforts.

Robex Resources has moved up the expiry date of its 2024 Warrants to October 2025 after its share price hit a key threshold, potentially unlocking C$147 million to fund its Kiniero Gold Project in Guinea.

Nexion Group has amended its sale agreement with Pier DC to include cancellation of an increased $1.75 million in Convertible Notes, reflecting recent fundraising. This adjustment marks a key step in the divestment of its Networks and Telecom units.

Central Petroleum Limited has reported a robust 43% increase in underlying EBITDAX for FY2025, alongside its inaugural on-market share buy-back, signaling confidence in its strengthened financial footing and growth prospects.

Aspermont Limited has raised an additional $891,210 through its Share Purchase Plan, complementing a recent $1.75 million institutional placement. This capital injection supports the company’s strategic pivot towards data-driven mining intelligence and AI-powered services.

BPH Global has raised $1.1 million through a private placement to expand its Indonesian seaweed operations and advance innovative R&D projects, positioning itself for growth in sustainable aquaculture and blue economy solutions.